CD 129 (Ranitidine 150 mg)

Pill imprint CD 129 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for CD 129

Ranitidine hydrochloride 150 mg CD 129 Front
Ranitidine hydrochloride 150 mg CD 129 Back
Ranitidine hydrochloride 150 mg CD 129
Ranitidine hydrochloride
Imprint:
CD
129
Strength:
150 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0129
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
titanium dioxide
gelatin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
49884-0647 Par Pharmaceutical

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)